Correlation Between IShares Global and VanEck Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both IShares Global and VanEck Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Global and VanEck Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between iShares Global Consumer and VanEck Pharmaceutical ETF, you can compare the effects of market volatilities on IShares Global and VanEck Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Global with a short position of VanEck Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Global and VanEck Pharmaceutical.

Diversification Opportunities for IShares Global and VanEck Pharmaceutical

-0.81
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between IShares and VanEck is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding iShares Global Consumer and VanEck Pharmaceutical ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on VanEck Pharmaceutical ETF and IShares Global is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Global Consumer are associated (or correlated) with VanEck Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of VanEck Pharmaceutical ETF has no effect on the direction of IShares Global i.e., IShares Global and VanEck Pharmaceutical go up and down completely randomly.

Pair Corralation between IShares Global and VanEck Pharmaceutical

Considering the 90-day investment horizon iShares Global Consumer is expected to generate 1.11 times more return on investment than VanEck Pharmaceutical. However, IShares Global is 1.11 times more volatile than VanEck Pharmaceutical ETF. It trades about 0.18 of its potential returns per unit of risk. VanEck Pharmaceutical ETF is currently generating about -0.19 per unit of risk. If you would invest  17,537  in iShares Global Consumer on August 28, 2024 and sell it today you would earn a total of  675.00  from holding iShares Global Consumer or generate 3.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

iShares Global Consumer  vs.  VanEck Pharmaceutical ETF

 Performance 
       Timeline  
iShares Global Consumer 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in iShares Global Consumer are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, IShares Global may actually be approaching a critical reversion point that can send shares even higher in December 2024.
VanEck Pharmaceutical ETF 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days VanEck Pharmaceutical ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Etf's basic indicators remain strong and the recent confusion on Wall Street may also be a sign of long-lasting gains for the Etf traders.

IShares Global and VanEck Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with IShares Global and VanEck Pharmaceutical

The main advantage of trading using opposite IShares Global and VanEck Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Global position performs unexpectedly, VanEck Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VanEck Pharmaceutical will offset losses from the drop in VanEck Pharmaceutical's long position.
The idea behind iShares Global Consumer and VanEck Pharmaceutical ETF pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges